Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Vaccines (Basel) ; 10(8)2022 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-36016100

RESUMO

Adjuvants and delivery systems are essential components of vaccines to increase immunogenicity against target antigens, particularly for peptide epitopes (poor immunogens). Emulsions, nanoparticles, and liposomes are commonly used as a delivery system for peptide-based vaccines. A Poly(hydrophobic amino acids) delivery system was previously conjugated to Group A Streptococcus (GAS)-derived peptide epitopes, allowing the conjugates to self-assemble into nanoparticles with self adjuvanting ability. Their hydrophobic amino acid tail also serves as an anchoring moiety for the peptide epitope, enabling it to be integrated into the liposome bilayer, to further boost the immunological responses. Polyleucine-based conjugates were anchored to cationic liposomes using the film hydration method and administered to mice subcutaneously. The polyleucine-peptide conjugate, its liposomal formulation, and simple liposomal encapsulation of GAS peptide epitope induced mucosal (saliva IgG) and systemic (serum IgG, IgG1 and IgG2c) immunity in mice. Polyleucine acted as a potent liposome anchoring portion, which stimulated the production of highly opsonic antibodies. The absence of polyleucine in the liposomal formulation (encapsulated GAS peptide) induced high levels of antibody titers, but with poor opsonic ability against GAS bacteria. However, the liposomal formulation of the conjugated vaccine was no more effective than conjugates alone self-assembled into nanoparticles.

2.
Sci Adv ; 6(5): eaax2285, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-32064333

RESUMO

To be optimally effective, peptide-based vaccines need to be administered with adjuvants. Many currently available adjuvants are toxic, not biodegradable; they invariably invoke adverse reactions, including allergic responses and excessive inflammation. A nontoxic, biodegradable, biocompatible, self-adjuvanting vaccine delivery system is urgently needed. Herein, we report a potent vaccine delivery system fulfilling the above requirements. A peptide antigen was coupled with poly-hydrophobic amino acid sequences serving as self-adjuvanting moieties using solid-phase synthesis, to produce fully defined single molecular entities. Under aqueous conditions, these molecules self-assembled into distinct nanoparticles and chain-like aggregates. Following subcutaneous immunization in mice, these particles successfully induced opsonic epitope-specific antibodies without the need of external adjuvant. Mice immunized with entities bearing 15 leucine residues were able to clear bacterial load from target organs without triggering the release of soluble inflammatory mediators. Thus, we have developed a well-defined and effective self-adjuvanting delivery system for peptide antigens.


Assuntos
Sistemas de Liberação de Medicamentos , Inflamação/prevenção & controle , Vacinas de Subunidades Antigênicas/farmacologia , Vacinas/farmacologia , Adjuvantes Imunológicos/farmacologia , Aminoácidos/química , Aminoácidos/imunologia , Animais , Materiais Biocompatíveis/química , Materiais Biocompatíveis/farmacologia , Epitopos/efeitos dos fármacos , Epitopos/imunologia , Humanos , Imunidade nas Mucosas/imunologia , Inflamação/imunologia , Camundongos , Nanopartículas/química , Vacinas/química , Vacinas/imunologia , Vacinas de Subunidades Antigênicas/química , Vacinas de Subunidades Antigênicas/imunologia
3.
Biometals ; 32(4): 707-715, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-31152280

RESUMO

The hydroxamate class of compounds is well known for its pharmacological applications, especially in the context of chelation therapy. In this work we investigate the performance of the fungal hydroxamates pyridoxatin (PYR), desferriastechrome (DAC) and desferricoprogen (DCO) as mitigators of stress caused by iron overload (IO) both in buffered medium and in cells. Desferrioxamine (DFO), the gold standard for IO treatment, was used as comparison. It was observed that all the fungal chelators (in aqueous medium) or PYR and DAC (in cells) are powerful iron scavengers. However only PYR and DCO (in aqueous medium) or PYR (in cells) were also antioxidant against two forms of iron-dependent oxidative stress (ascorbate or peroxide oxidation). These findings reveal that PYR is an interesting alternative to DFO for iron chelation therapy, since it has the advantage of being cell permeable and thus potentially orally active.


Assuntos
Antioxidantes/química , Dicetopiperazinas/química , Ácidos Hidroxâmicos/química , Cicloexanos/química , Quelantes de Ferro/química , Sobrecarga de Ferro/metabolismo
4.
Fitoterapia ; 126: 83-89, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28888966

RESUMO

Chemical investigation of two Irciniidae sponges collected by hand (SCUBA) from Australian near shore waters, afforded six new examples of a rare class of sesterterpene lactam; ircinialactams B (1), G (2), H (5), and I (6), and 8-hydroxyircinialactams C (3) and G (4); together with the new biosynthetically related lactone, ircinialactone A (7). Also isolated were seven biosynthetically related known Irciniidae metabolites; ircinialactams A (8) and C (9), (7E,12E,20Z,18S)-variabilin (10), (7Z,12Z,20Z,18S)-variabilin (11), (7E,12Z,20Z,18S)-variabilin (12), (7Z,12E,20Z,18S)-variabilin (13) and irciniafuran A (14). The structure elucidation of 1-14 was achieved by detailed spectroscopic analysis, and consideration of a plausible biosynthetic relationship linking Irciniidae sesterterpene ß-furans, lactams and lactones.


Assuntos
Lactamas/química , Poríferos/química , Sesterterpenos/química , Animais , Lactamas/isolamento & purificação , Estrutura Molecular , New South Wales , Proteínas/química , Sesterterpenos/isolamento & purificação
5.
Curr Drug Deliv ; 12(1): 108-14, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25213074

RESUMO

Despite the increasing need for antibiotics to fight infectious diseases, fewer new antibiotics are available on the market. Unfortunately, developing a new class of antibiotics is associated with high commercial risk. Therefore, modification or combination of existing antibiotics to improve their efficacy is a promising strategy. Herein, we conjugated the antibiotic, levofloxacin, with two peptides, i.e. an antimicrobial peptide indolicidin and a cell penetrating peptide (TAT). Glycolic acid and glycine linkers were used between levofloxacin and peptides. We developed an optimized condition for coupling of levofloxacin via its carboxylic group to glycolic acid using solid phase peptide synthesis (SPPS). Antibacterial and haemolytic assays were carried out on the conjugates and only the levofloxacin-indolicidin conjugate demonstrated moderate antibacterial activity. Interestingly, physical mixture of levofloxacin and indolicidin showed improvement in the activity against Gram-positive bacteria.


Assuntos
Antibacterianos/farmacologia , Peptídeos Catiônicos Antimicrobianos/farmacologia , Bactérias Gram-Positivas/efeitos dos fármacos , Levofloxacino/farmacologia , Antibacterianos/química , Antibacterianos/metabolismo , Antibacterianos/toxicidade , Peptídeos Catiônicos Antimicrobianos/química , Peptídeos Catiônicos Antimicrobianos/metabolismo , Peptídeos Catiônicos Antimicrobianos/toxicidade , Peptídeos Penetradores de Células/química , Peptídeos Penetradores de Células/metabolismo , Química Farmacêutica , Portadores de Fármacos , Combinação de Medicamentos , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/crescimento & desenvolvimento , Bactérias Gram-Positivas/crescimento & desenvolvimento , Hemólise/efeitos dos fármacos , Humanos , Levofloxacino/química , Levofloxacino/metabolismo , Levofloxacino/toxicidade , Testes de Sensibilidade Microbiana , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/metabolismo , Técnicas de Síntese em Fase Sólida , Tecnologia Farmacêutica/métodos , Produtos do Gene tat do Vírus da Imunodeficiência Humana/química , Produtos do Gene tat do Vírus da Imunodeficiência Humana/metabolismo
6.
Nat Prod Res ; 18(4): 305-9, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15214481

RESUMO

Bioassay directed fractionation of a Raspailia (Raspailia) sp. (Order Poecilosclerida; Family Raspailiidae) collected during scientific trawling operations off the Northern Rottnest Shelf yielded as nematocidal agents the known metabolites, phorboxazoles A (1) and B (2). Further examination revealed the new natural product but known synthetic compound, esmodil (3). The structure for 3 was confirmed by spectroscopic analysis and total synthesis.


Assuntos
Antinematódeos/farmacologia , Hemoncose/prevenção & controle , Haemonchus/efeitos dos fármacos , Cloreto de Metacolina/farmacologia , Fitoterapia , Poríferos , Animais , Antinematódeos/administração & dosagem , Antinematódeos/uso terapêutico , Cloreto de Metacolina/administração & dosagem , Cloreto de Metacolina/análogos & derivados , Cloreto de Metacolina/uso terapêutico , Testes de Sensibilidade Parasitária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA